PoLoPo is a food-tech company developing a plant bio-factory for high-scale, custom-made production of proteins. The company’s proprietary technology allows proteins to be expressed in potatoes in a scalable, cost-effective way. The company claims its ovalbumin (the primary protein found in egg white, making up approximately 55% of the total protein) will be identical to chicken egg ovalbumin in terms of functionality, nutritional value, and protein sequence.
In March 2024, the company unveiled its molecular farming platform SuperAA, which uses metabolic engineering to convert potato plants into protein-producing micro-biofactories. As its initial products, the company was developing ovalbumin and patanin, which offer various Food Tech applications, including developing plant-based eggs and dairy alternatives. Following this, in May 2024, the company applied for a Regulatory Status Review (RSR) from the US Department of Agriculture's Animal and Plant Health Inspection Service for its platform.
Funding and financials
In March 2023, PoLoPo raised USD 1.75 million in a pre-seed funding round to support the company’s technology platform. The round was led by FoodLabs, with participation from several investors including CPT Capital, Siddhi Capital, and Milk & Honey Ventures.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.